Freeze or pills? new study battles persistent AF

NCT ID NCT03716934

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study compared two treatments for persistent atrial fibrillation (an irregular heartbeat): cryoablation (freezing tiny areas of heart tissue) and antiarrhythmic drugs. 196 patients were randomly assigned to one treatment and monitored for over a year. The goal was to see which approach better prevents heart rhythm problems and major complications like stroke or heart attack.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
cryoablation (freezing heart tissue) or antiarrhythmic drugs
What this could lead to
If cryoablation proves safer or more effective than drugs, it could become a preferred treatment for persistent atrial fibrillation, reducing symptoms and complications.
What could go wrong
This is a completed Phase 4 trial with 196 patients, so results are limited. Cryoablation carries risks like stroke, heart damage, or need for a pacemaker, and may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fundacion para Investigación Biomedica Hospital Clinico San Carlos

    Madrid, Madrid, 28040, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.